Lynn Seely

2017

In 2017, Lynn Seely earned a total compensation of $12.2M as Principal Executive Officer at Myovant Sciences Ltd., a 96% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$230,400
Option Awards$3,404,171
Salary$525,569
Stock Awards$7,999,094
Total$12,159,234

Seely received $8M in stock awards, accounting for 66% of the total pay in 2017.

Seely also received $230.4K in non-equity incentive plan, $3.4M in option awards and $525.6K in salary.

Rankings

In 2017, Lynn Seely's compensation ranked 437th out of 14,666 executives tracked by ExecPay. In other words, Seely earned more than 97.0% of executives.

ClassificationRankingPercentile
All
437
out of 14,666
97th
Division
Manufacturing
139
out of 5,772
98th
Major group
Chemicals And Allied Products
34
out of 2,075
98th
Industry group
Drugs
24
out of 1,731
99th
Industry
Pharmaceutical Preparations
21
out of 1,333
98th
Source: SEC filing on July 25, 2018.

Seely's colleagues

We found two more compensation records of executives who worked with Lynn Seely at Myovant Sciences Ltd. in 2017.

2017

Matthew Lang

Myovant Sciences Ltd.

General Counsel

2017

Frank Karbe

Myovant Sciences Ltd.

Principal Financial and Accounting Officer

News

You may also like